APOE is a potential modifier gene in an autosomal dominant form of frontotemporal dementia (IBMPFD).
| Author | |
|---|---|
| Abstract | :  Inclusion-body myopathy, Paget's disease of bone and frontotemporal dementia is an adult-onset autosomal dominant illness (IBMPFD) caused by mutations in the valosin-containing protein (VCP) on chromosome 9p21.1-p12. The penetrance of the gene is 82% for myopathy, 49% for Paget's disease, but may be as low as 30% for frontotemporal dementia. Modifier genes could account for decreased frontotemporal dementia penetrance. In this study apolipoprotein-E (APOE) was evaluated for this role in IBMPFD families based on its known modifier effect in Alzheimer's disease. | 
| Year of Publication | :  2007 | 
| Journal | :  Genetics in medicine : official journal of the American College of Medical Genetics | 
| Volume | :  9 | 
| Issue | :  1 | 
| Number of Pages | :  9-13 | 
| ISSN Number | :  1098-3600 | 
| URL | :  https://linkinghub.elsevier.com/retrieve/pii/00125817-200701000-00003 | 
| DOI | :  10.1097/gim.0b013e31802d830d | 
| Short Title | :  Genet Med | 
| Download citation |